A Novel, Silk-Derived, Inflammation Based Therapy
We developed amlisimod, a non-toxic, anti-inflammatory biotherapy using natural silk-derived protein - designed specifically to reduce inflammation without side effects.
what is the solution?
The Amlisimod Protein
Amlisimod is a repeating combination of amino acids, called peptides. These form different sized proteins with similar anti-inflammatory capabilities.
How Does It Work?
Potential Indication Platform for Auto-Inflammatory Diseases
Amlisimod's mechanism of action could allow for therapeutic use in additional diseases, like dry eye disease, diabetes, sepsis, and other inflammation based indications.
About Silk Tech
SilkTech Biopharmaceuticals is a drug discovery and development company specializing in the isolation and cGMP manufacturing of patented silk-derived proteins (SDP) from the domesticated Bombyx mori silkworm cocoon.
Meet Executive Team